CLEW, a leading provider of AI-driven clinical surveillance solutions, announced the launch of its Sepsis Virtual Unit (SVU), designed to help healthcare organizations improve sepsis detection, enhance SEP-1 compliance, and drive better patient outcomes. The CLEW SVU provides real-time AI-powered monitoring and surveillance, enabling clinicians to detect sepsis earlier, ensure timely interventions, and streamline compliance with evolving regulatory requirements.
With CMS increasing enforcement of SEP-1 compliance, hospitals now face greater financial penalties and reimbursement risks tied to their adherence to sepsis treatment protocols. Starting in 2024, CMS has linked SEP-1 performance more directly to Value Based Purchasing (VBP) incentives, meaning hospitals that fail to meet compliance standards risk reduced reimbursements and increased financial penalties. Given that sepsis accounts for nearly $62 billion in annual healthcare costs and is a leading cause of hospital mortality, healthcare systems must act swiftly to improve protocol adherence. The CLEW SVU enables hospitals to stay ahead of these changes by offering centralized, real-time monitoring, automated SEP-1 bundle tracking, and actionable insights, helping providers reduce sepsis-related mortality, optimize workflows, and safeguard reimbursements.
Also Read: Enveric Biosciences Opens RFP for PsyAI Trademark
“Sepsis remains one of the leading causes of hospital mortality and costs, and regulatory requirements continue to push for better compliance and outcomes,” said Noa Berger, VP Product at CLEW. “Our Sepsis Virtual Unit provides organizations with the tools they need to detect sepsis earlier, improve protocol adherence, and ultimately save more lives.”
The CLEW SVU seamlessly integrates with any EMR, ensuring quick adoption without disrupting existing workflows.
By helping hospitals and healthcare systems stay ahead of SEP-1 regulatory requirements, CLEW‘s Sepsis Virtual Unit empowers organizations to deliver higher-quality care, reduce sepsis-related penalties, and improve both clinical and financial outcomes.
Source: PRNewswire